INVZ |
Innoviz Technologies Ltd. |
Ordinary Shares, no par value |
9.9% |
$13.3M |
$3.91M |
20.4M |
+41.8% |
CVI Investments, Inc. |
Feb 10, 2025 |
RSLS |
ReShape Lifesciences Inc. |
Common Stock, par value $0.001 per share |
9.9% |
$134K |
|
345K |
|
CVI Investments, Inc. |
Feb 18, 2025 |
SLXN |
Silexion Therapeutics Corp |
Ordinary Shares, par value $0.0009 per share |
8.5% |
$373K |
|
339K |
|
CVI Investments, Inc. |
Jan 15, 2025 |
FGMCU |
FG Merger II Corp. |
Common Stock, par value $0.0001 per share |
7.7% |
$7.72M |
|
790K |
|
CVI Investments, Inc. |
Jan 29, 2025 |
BNGO |
Bionano Genomics, Inc. |
Common Stock, par value $0.0001 per share |
7.7% |
$1.28M |
|
10.7M |
|
CVI Investments, Inc. |
Jan 3, 2025 |
AEI |
Alset Inc. |
Common Stock, $0.001 par value per share |
7% |
$741K |
|
750K |
|
CVI Investments, Inc. |
Jan 2, 2025 |
ICON |
Icon Energy Corp. |
Common Stock, par value $0.001 per share |
6.9% |
$73.4K |
|
734K |
|
CVI Investments, Inc. |
Jan 23, 2025 |
APVO |
Aptevo Therapeutics Inc. |
Common Stock, $0.001 par value per share |
6.2% |
$224K |
|
200K |
|
CVI Investments, Inc. |
Apr 3, 2025 |
MBOT |
Microbot Medical Inc. |
Common Stock, par value $0.01 per share |
6.1% |
$1.9M |
|
1.26M |
|
CVI Investments, Inc. |
Jan 6, 2025 |
ANVS |
Annovis Bio, Inc. |
Common Stock, par value $0.0001 per share |
5.1% |
$1.5M |
|
1M |
|
CVI Investments, Inc. |
Feb 3, 2025 |
RVPH |
Reviva Pharmaceuticals Holdings, Inc. |
Common Stock, par value $0.0001 per share |
4.9% |
$2.33M |
-$846K |
2.45M |
-26.6% |
CVI Investments, Inc. |
Dec 31, 2024 |
GXAI |
Gaxos.ai Inc. |
Common Stock, par value $0.0001 per share |
4.9% |
$440K |
-$174K |
364K |
-28.3% |
CVI Investments, Inc. |
Dec 31, 2024 |
AMIX |
Autonomix Medical, Inc. |
Common Stock, $0.001 par value per share |
4.9% |
$203K |
|
116K |
|
CVI Investments, Inc. |
Dec 31, 2024 |
TOVX |
Theriva Biologics, Inc. |
Common Stock, $0.001 par value per share |
4.9% |
$177K |
|
146K |
|
CVI Investments, Inc. |
Dec 31, 2024 |
PHIO |
Phio Pharmaceuticals Corp. |
Common Stock, par value $0.0001 per share |
4.9% |
$117K |
-$23.6K |
91K |
-16.8% |
CVI Investments, Inc. |
Dec 31, 2024 |
ATOS |
Atossa Therapeutics, Inc. |
Common Stock, $0.18 par value per share |
4.3% |
$3.81M |
|
5.66M |
|
CVI Investments, Inc. |
Dec 31, 2024 |
PSQH |
PSQ Holdings, Inc. |
Class A Common Stock, $0.0001 par value per share |
3.3% |
$2.93M |
|
1.29M |
|
CVI Investments, Inc. |
Dec 31, 2024 |
RGTI |
Rigetti Computing, Inc. |
Common Stock, $0.0001 par value per share |
0% |
$0 |
|
0 |
|
CVI Investments, Inc. |
Dec 31, 2024 |
CADL |
Candel Therapeutics, Inc. |
Common Stock, $0.01 par value per share |
0% |
$0 |
|
0 |
|
CVI Investments, Inc. |
Dec 31, 2024 |
LITM |
Snow Lake Resources Ltd. |
Common Shares, no par value |
0% |
$0 |
-$2.57M |
0 |
-100% |
CVI Investments, Inc. |
Dec 31, 2024 |